Unicycive Therapeutics, Inc. — Form 8-K
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Unicycive Therapeutics filed an 8-K on 2026-09-28 reporting a period ending 2026-09-03. The filing contains Item 8.01 (Other Events) but the specific details of the event are not disclosed in the header information provided. No dollar amounts, counterparties, or material transactions are stated in the available text.
Why this rating
No material facts disclosed; header-only filing with unspecified 'Other Events' item. Cannot assess business impact without event details.
Extracted items
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.